The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
![Ann D Thor](/images/no-picture.png)
![Glenn Furuta](/images/no-picture.png)
![Robert C Doebele](/pictures/9a/1773597.jpg)
![Peter L Anderson](/pictures/19/1773603.jpg)
![Lisa A Brenner](/pictures/62/1773619.jpg)
![Carlos Franco Paredes](/pictures/cf/1773614.jpg)
![R Paul Wadwa](/pictures/a7/1773637.jpg)
![Travis Nemkov](/pictures/eb/1773666.jpg)
![Viral N Shah](/pictures/c4/1773681.jpg)
![Petter Bjornstad](/pictures/d7/4684820.jpg)
![Kristine M Erlandson](/pictures/4a/1773684.jpg)
![Melanie Cree-Green|Melanie Cree-Green,](/pictures/24/4684814.jpg)
![Jamie L Studts](/pictures/ea/1773623.jpg)
![Dmitri Simberg](/pictures/87/1773654.jpg)
![Christopher Lieu](/images/no-picture.png)
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
4 | 4,955 | 5,406 | 10,833 |
|
![]() |
![]() |
Others
|
94 | 53 | 0.564 | 242 | 186 | 0.769 | 28,401 | 9,984 | 0.352 |
7 | 6,548 | 7,154 | 14,520 |
|
![]() |
![]() |
Others
breast cancer pathobiology | |
87 | 33 | 0.379 | 195 | 82 | 0.421 | 31,468 | 4,003 | 0.127 |
9 | 8,710 | 9,548 | 19,739 |
|
![]() |
![]() |
Others
eosinophilic gastrointestinal diseases | eosinophilic esophagitis | eosinophilic gastritis | eosinophilic colitis | |
79 | 58 | 0.734 | 222 | 172 | 0.775 | 33,552 | 14,691 | 0.438 |
11 | 8,844 | 9,698 | 20,081 |
|
![]() |
![]() |
Others
|
79 | 46 | 0.582 | 277 | 198 | 0.715 | 22,323 | 9,130 | 0.409 |
13 | 10,555 | 11,613 | 24,382 |
|
![]() |
![]() |
Others
Oncogenes (ALK | ROS1 | RET | EGFR | NTRK) and drug resistance | |
74 | 62 | 0.838 | 193 | 157 | 0.813 | 31,812 | 21,187 | 0.666 |
16 | 11,636 | 12,812 | 27,106 |
|
![]() |
![]() |
Others
|
72 | 46 | 0.639 | 146 | 111 | 0.760 | 22,809 | 9,286 | 0.407 |
20 | 14,656 | 16,241 | 35,090 |
|
![]() |
![]() |
Others
antiviral pharmacology | |
66 | 50 | 0.758 | 217 | 176 | 0.811 | 22,903 | 12,711 | 0.555 |
22 | 16,449 | 18,263 | 39,907 |
|
![]() |
![]() |
Others
Medicine | |
64 | 27 | 0.422 | 120 | 66 | 0.550 | 17,515 | 3,161 | 0.180 |
27 | 18,741 | 20,840 | 46,150 |
|
![]() |
![]() |
Others
Cancer research | |
61 | 26 | 0.426 | 124 | 63 | 0.508 | 13,301 | 3,047 | 0.229 |
28 | 21,397 | 23,884 | 53,756 |
|
![]() |
![]() |
Others
|
57 | 48 | 0.842 | 117 | 107 | 0.915 | 11,968 | 8,167 | 0.682 |
![]() |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
![]() |
||||||||||||||
29 | 22,442 | 25,073 | 56,842 |
|
![]() |
![]() |
Others
Traumatic Brain Injury | Suicide Prevention | Microbiome | PTSD | Veterans | |
56 | 42 | 0.750 | 162 | 145 | 0.895 | 11,686 | 7,057 | 0.604 |
31 | 22,725 | 25,399 | 57,733 |
|
![]() |
![]() |
Others
Tropical and Travel Medicine | |
56 | 35 | 0.625 | 184 | 130 | 0.707 | 14,590 | 9,479 | 0.650 |
34 | 23,318 | 26,050 | 59,294 |
|
![]() |
![]() |
Others
type 1 diabetes | telemedicine | diabetes technology | |
55 | 48 | 0.873 | 133 | 117 | 0.880 | 11,070 | 7,568 | 0.684 |
38 | 26,503 | 29,679 | 68,801 |
|
![]() |
![]() |
Others
Metabolomics | Proteomics | Red Blood Cells | Exercise Metabolism | |
52 | 47 | 0.904 | 115 | 113 | 0.983 | 9,108 | 8,024 | 0.881 |
42 | 29,446 | 33,045 | 77,964 |
|
![]() |
![]() |
Others
|
50 | 34 | 0.680 | 99 | 78 | 0.788 | 9,438 | 4,609 | 0.488 |
44 | 32,107 | 36,096 | 86,412 |
|
![]() |
![]() |
Others
|
48 | 33 | 0.688 | 133 | 77 | 0.579 | 7,846 | 3,534 | 0.450 |
48 | 34,603 | 38,913 | 94,215 |
|
![]() |
![]() |
Others
Type 1 diabetes and Bone metabolism | |
46 | 41 | 0.891 | 109 | 93 | 0.853 | 7,519 | 6,076 | 0.808 |
49 | 36,249 | 40,778 | 99,486 |
|
![]() |
![]() |
Others
Type 1 Diabetes | Microvascular complications | Macrovascular complications | Epidemiology | |
45 | 38 | 0.844 | 126 | 119 | 0.944 | 6,989 | 5,809 | 0.831 |
50 | 36,251 | 40,780 | 99,502 |
|
![]() |
![]() |
Others
HIV | aging | exercise | physical function | sarcopenia | |
45 | 38 | 0.844 | 112 | 105 | 0.938 | 7,338 | 6,164 | 0.840 |
52 | 36,592 | 41,173 | 100,761 |
|
![]() |
![]() |
Others
Polycystic Ovary Syndrome | Obesity | Insulin Resistance | |
45 | 33 | 0.733 | 101 | 86 | 0.851 | 8,107 | 4,496 | 0.555 |
54 | 37,031 | 41,705 | 102,317 |
|
![]() |
![]() |
Others
|
45 | 28 | 0.622 | 76 | 52 | 0.684 | 7,818 | 3,311 | 0.424 |
59 | 39,220 | 44,233 | 109,362 |
|
![]() |
![]() |
Others
|
44 | 21 | 0.477 | 74 | 37 | 0.500 | 7,102 | 1,413 | 0.199 |
63 | 40,373 | 45,535 | 113,310 |
|
![]() |
![]() |
Others
Cancer Prevention and Control | |
43 | 28 | 0.651 | 88 | 62 | 0.705 | 9,163 | 2,939 | 0.321 |
74 | 50,519 | 57,074 | 148,135 |
|
![]() |
![]() |
Others
Drug delivery | immune recognition of nanoparticles | lipid and iron oxide nanoparticles | |
38 | 28 | 0.737 | 69 | 58 | 0.841 | 5,925 | 3,187 | 0.538 |
79 | 52,110 | 58,895 | 153,596 |
|
![]() |
![]() |
Others
Cancer | Targeted Therapeutics | Colorectal Cancer | |
37 | 34 | 0.919 | 79 | 69 | 0.873 | 8,339 | 6,141 | 0.736 |